Article
Paraoxonase 1 Activity Is Modulated by the rs662 Polymorphism and IgG Anti-High-Density Lipoprotein Antibodies in Patients With Rheumatoid Arthritis: Potential Implications for Cardiovascular Disease.
Arthritis & rheumatology (Hoboken, N.J.) - 1 Jun 2016
Rodríguez-Carrio Javier, López-Mejías Raquel, Alperi-López Mercedes, López Patricia, Ballina-García Francisco J, González-Gay Miguel Á, Suárez Ana
Abstract excerpt
OBJECTIVE: Paraoxonase 1 (PON-1) is a high-density lipoprotein (HDL)-associated antioxidant enzyme that plays an important role in HDL-mediated cardioprotection. Although genetic polymorphisms are known to modulate PON-1 activity, its involvement in cardiovascular disease (CVD) in rheumatoid arthritis (RA) is controversial, suggesting that other factors may modulate its function. Since anti-HDL antibodies have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
